- Home
- CLRB vs ANY Comparison
CLRB vs ANY Comparison
Compare CLRB & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- ANY
- Stock Information
- Founded
- CLRB 2002
- ANY N/A
- Country
- CLRB United States
- ANY United States
- Employees
- CLRB N/A
- ANY N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- ANY Finance: Consumer Services
- Sector
- CLRB Health Care
- ANY Finance
- Exchange
- CLRB Nasdaq
- ANY Nasdaq
- Market Cap
- CLRB 12.8M
- ANY 14.7M
- IPO Year
- CLRB N/A
- ANY N/A
- Fundamental
- Price
- CLRB $2.88
- ANY $0.47
- Analyst Decision
- CLRB Hold
- ANY Strong Buy
- Analyst Count
- CLRB 2
- ANY 1
- Target Price
- CLRB N/A
- ANY $3.00
- AVG Volume (30 Days)
- CLRB 90.4K
- ANY 578.8K
- Earning Date
- CLRB 11-13-2025
- ANY 11-04-2025
- Dividend Yield
- CLRB N/A
- ANY N/A
- EPS Growth
- CLRB N/A
- ANY N/A
- EPS
- CLRB N/A
- ANY N/A
- Revenue
- CLRB N/A
- ANY $11,099,000.00
- Revenue This Year
- CLRB N/A
- ANY N/A
- Revenue Next Year
- CLRB N/A
- ANY $36.07
- P/E Ratio
- CLRB N/A
- ANY N/A
- Revenue Growth
- CLRB N/A
- ANY N/A
- 52 Week Low
- CLRB $2.71
- ANY $0.36
- 52 Week High
- CLRB $48.90
- ANY $1.67
- Technical
- Relative Strength Index (RSI)
- CLRB 33.08
- ANY 33.97
- Support Level
- CLRB $2.78
- ANY $0.42
- Resistance Level
- CLRB $3.15
- ANY $0.51
- Average True Range (ATR)
- CLRB 0.25
- ANY 0.05
- MACD
- CLRB 0.01
- ANY -0.01
- Stochastic Oscillator
- CLRB 16.83
- ANY 20.54
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About ANY Sphere 3D Corp.
Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.